SAN ANTONIO--(BUSINESS WIRE)--bioAffinity Technologies, a privately held biotech company advancing innovative cancer diagnostics, announced that ...
News
- bioAffinity Technologies Announces Precision Pathology Services' Validation of Novel Non ...
- Spirit AeroSystems, Hess rise; Dynavax, TransUnion fall - mySA
Regenxbio Inc., up $10.32 to $43.40. The biotechnology company is collaborating with AbbVie on eye-condition treatments. Dynavax Technologies Corp., ...
- Liberty U resumes in-person classes - Inside Higher Ed
A University of Texas at San Antonio statement said: "Based on the most ... Kirstyn Katherine Ahuero was a sophomore biomedical engineering major.
- UTRGV and UT Health Science Center San Antonio selected as NIA... - Mega Doctor News
RIO GRANDE VALLEY / SAN ANTONIO, TEXAS – The University of Texas Rio ... dentistry, health professions and graduate biomedical sciences have ...
- Initial public offerings scheduled to debut next week - mySA
Proposed Nasdaq symbol DICE. Business: Phase 1-ready biotech developing oral small molecule therapies for immunologic. Dutch Bros - Grants Pass, ...